drugset / Trial / NCT02223507
Single Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Elderly Male and Female Volunteers
RandomizedParallel-groupSingle-blindTreatment
Summary
The objective of the present study was to obtain information about the safety, tolerability and pharmacokinetics of BIIR 561 CL after continuous intravenous administration of two increasing doses in healthy elderly volunteers, following the infusion schema of a loading dose (1 hour) and a maintenance dose (5 hours)
Timeline
- Start
- 2000-08
- Primary completion
- 2000-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IRAMPANEL | Small molecule | 40 mg | Intravenous |
| Subject | IRAMPANEL | Small molecule | 75 mg | Intravenous |
Indications
No indication recorded.